SG11202011003TA - Azabenzimidazole compounds and pharmaceutical - Google Patents
Azabenzimidazole compounds and pharmaceuticalInfo
- Publication number
- SG11202011003TA SG11202011003TA SG11202011003TA SG11202011003TA SG11202011003TA SG 11202011003T A SG11202011003T A SG 11202011003TA SG 11202011003T A SG11202011003T A SG 11202011003TA SG 11202011003T A SG11202011003T A SG 11202011003TA SG 11202011003T A SG11202011003T A SG 11202011003TA
- Authority
- SG
- Singapore
- Prior art keywords
- pharmaceutical
- azabenzimidazole compounds
- azabenzimidazole
- compounds
- Prior art date
Links
- GAMYYCRTACQSBR-UHFFFAOYSA-N 4-azabenzimidazole Chemical class C1=CC=C2NC=NC2=N1 GAMYYCRTACQSBR-UHFFFAOYSA-N 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/396—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having three-membered rings, e.g. aziridine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/444—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring heteroatom, e.g. amrinone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/4545—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring hetero atom, e.g. pipamperone, anabasine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/4965—Non-condensed pyrazines
- A61K31/497—Non-condensed pyrazines containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Urology & Nephrology (AREA)
- Diabetes (AREA)
- Ophthalmology & Optometry (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2018089867 | 2018-05-08 | ||
| PCT/JP2019/018201 WO2019216294A1 (ja) | 2018-05-08 | 2019-05-07 | アザベンゾイミダゾール化合物及び医薬 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11202011003TA true SG11202011003TA (en) | 2020-12-30 |
Family
ID=68467433
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11202011003TA SG11202011003TA (en) | 2018-05-08 | 2019-05-07 | Azabenzimidazole compounds and pharmaceutical |
Country Status (22)
| Country | Link |
|---|---|
| US (1) | US20210371412A1 (zh) |
| EP (1) | EP3792260A4 (zh) |
| JP (1) | JP7235047B2 (zh) |
| KR (1) | KR20210006437A (zh) |
| CN (1) | CN112368282B (zh) |
| AU (1) | AU2019265134B2 (zh) |
| BR (1) | BR112020022662A2 (zh) |
| CA (1) | CA3099655A1 (zh) |
| CL (1) | CL2020002868A1 (zh) |
| CO (1) | CO2020013848A2 (zh) |
| EC (1) | ECSP20078586A (zh) |
| IL (1) | IL278517B1 (zh) |
| MA (1) | MA52587A (zh) |
| MX (1) | MX2020011855A (zh) |
| PE (1) | PE20211384A1 (zh) |
| PH (1) | PH12020551873A1 (zh) |
| SA (1) | SA520420487B1 (zh) |
| SG (1) | SG11202011003TA (zh) |
| TW (1) | TW202016108A (zh) |
| UA (1) | UA126774C2 (zh) |
| WO (1) | WO2019216294A1 (zh) |
| ZA (1) | ZA202007164B (zh) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPWO2021095801A1 (zh) * | 2019-11-13 | 2021-05-20 | ||
| CA3160838A1 (en) * | 2019-11-13 | 2021-05-20 | Nippon Shinyaku Co., Ltd. | Therapeutic agents and prophylactic agents for functional gastrointestinal disorders and xerostomia |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2274712B1 (es) * | 2005-10-06 | 2008-03-01 | Laboratorios Almirall S.A. | Nuevos derivados imidazopiridina. |
| AU2009207693A1 (en) * | 2008-01-24 | 2009-07-30 | Ucb Pharma, S.A. | Compounds comprising a cyclobutoxy group |
| JP5667934B2 (ja) * | 2010-06-28 | 2015-02-12 | 大日本住友製薬株式会社 | 新規２環性複素環化合物からなる医薬 |
| US20140135319A1 (en) * | 2010-12-17 | 2014-05-15 | Bayer Intellectual Property Gmbh | 6-substituted imidazopyrazines for use as mps-1 and tkk inhibitors in the treatment of hyperproliferative disorders |
| WO2012080230A1 (en) * | 2010-12-17 | 2012-06-21 | Bayer Pharma Aktiengesellschaft | 6 substituted imidazopyrazines for use as mps-1 and tkk inhibitors in the treatment of hyperproliferative disorders |
| GB201302927D0 (en) * | 2013-02-20 | 2013-04-03 | Cancer Therapeutics Crc Pty Ltd | Compounds |
-
2019
- 2019-05-07 MX MX2020011855A patent/MX2020011855A/es unknown
- 2019-05-07 US US17/053,380 patent/US20210371412A1/en active Pending
- 2019-05-07 CN CN201980046177.6A patent/CN112368282B/zh active Active
- 2019-05-07 IL IL278517A patent/IL278517B1/en unknown
- 2019-05-07 WO PCT/JP2019/018201 patent/WO2019216294A1/ja active Application Filing
- 2019-05-07 CA CA3099655A patent/CA3099655A1/en active Pending
- 2019-05-07 KR KR1020207035176A patent/KR20210006437A/ko not_active Application Discontinuation
- 2019-05-07 UA UAA202007681A patent/UA126774C2/uk unknown
- 2019-05-07 EP EP19800286.7A patent/EP3792260A4/en active Pending
- 2019-05-07 BR BR112020022662-9A patent/BR112020022662A2/pt unknown
- 2019-05-07 PE PE2020001816A patent/PE20211384A1/es unknown
- 2019-05-07 AU AU2019265134A patent/AU2019265134B2/en active Active
- 2019-05-07 JP JP2020518289A patent/JP7235047B2/ja active Active
- 2019-05-07 SG SG11202011003TA patent/SG11202011003TA/en unknown
- 2019-05-07 MA MA052587A patent/MA52587A/fr unknown
- 2019-05-08 TW TW108115846A patent/TW202016108A/zh unknown
-
2020
- 2020-11-05 SA SA520420487A patent/SA520420487B1/ar unknown
- 2020-11-05 CO CONC2020/0013848A patent/CO2020013848A2/es unknown
- 2020-11-05 PH PH12020551873A patent/PH12020551873A1/en unknown
- 2020-11-05 CL CL2020002868A patent/CL2020002868A1/es unknown
- 2020-11-17 ZA ZA2020/07164A patent/ZA202007164B/en unknown
- 2020-12-07 EC ECSENADI202078586A patent/ECSP20078586A/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AU2019265134B2 (en) | 2024-02-29 |
| MA52587A (fr) | 2021-03-17 |
| IL278517B1 (en) | 2024-05-01 |
| PE20211384A1 (es) | 2021-07-27 |
| IL278517A (en) | 2020-12-31 |
| KR20210006437A (ko) | 2021-01-18 |
| SA520420487B1 (ar) | 2024-03-17 |
| CN112368282B (zh) | 2023-10-13 |
| CO2020013848A2 (es) | 2021-01-29 |
| ECSP20078586A (es) | 2021-01-29 |
| UA126774C2 (uk) | 2023-02-01 |
| TW202016108A (zh) | 2020-05-01 |
| ZA202007164B (en) | 2024-06-26 |
| PH12020551873A1 (en) | 2021-05-31 |
| WO2019216294A1 (ja) | 2019-11-14 |
| CN112368282A (zh) | 2021-02-12 |
| US20210371412A1 (en) | 2021-12-02 |
| MX2020011855A (es) | 2021-01-20 |
| EP3792260A1 (en) | 2021-03-17 |
| CL2020002868A1 (es) | 2021-04-16 |
| JPWO2019216294A1 (ja) | 2021-05-13 |
| CA3099655A1 (en) | 2019-11-14 |
| EP3792260A4 (en) | 2022-02-09 |
| AU2019265134A1 (en) | 2020-12-17 |
| BR112020022662A2 (pt) | 2021-02-09 |
| JP7235047B2 (ja) | 2023-03-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB2569961B (en) | Pharmaceutical | |
| IL276232A (en) | pharmaceutical compounds | |
| GB2572126B (en) | Pharmaceutical | |
| GB2572125B (en) | Pharmaceutical | |
| GB201807942D0 (en) | Pharmaceutical formulation | |
| IL271226A (en) | medical preparation | |
| GB201810245D0 (en) | Pharmaceutical compounds | |
| GB201810239D0 (en) | Pharmaceutical compounds | |
| GB201819961D0 (en) | Pharmaceutical compounds | |
| IL283900A (en) | Pharmaceutical combinations | |
| GB201819960D0 (en) | Pharmaceutical compounds | |
| ZA202102871B (en) | Pharmaceutical formulation | |
| IL269239A (en) | A pharmaceutical combination containing fonsimod | |
| IL278927A (en) | pharmaceutical preparation | |
| IL276323A (en) | 4-Methyldihydropyrimidinone compounds and their pharmaceutical use | |
| IL277334A (en) | Pharmaceutical combinations | |
| IL278517A (en) | Azabenzaimidazole compounds and pharmaceutical preparations | |
| PL3601277T3 (pl) | Preparat farmaceutyczny | |
| GB201801562D0 (en) | Pharmaceutical compounds | |
| GB201800378D0 (en) | Pharmaceutical compounds | |
| IL279334A (en) | Pharmaceutical combinations | |
| GB201816369D0 (en) | Pharmaceutical compounds | |
| IL283273A (en) | Pharmacy practices | |
| ZA202006346B (en) | Pharmaceutical preparation | |
| IL275144A (en) | Pharmacy preparation |